drugset / Trial / NCT06513013

MgSO4 as Adjuvants to Bupivacaine vs Neostigmine in TAP Block in Cesarean Section

NCT06513013

Phase 2/3 Completed 68 enrolled Assiut University
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to compare the duration of analgesia obtained by addition of Neostigmine versus MgSO4 as adjuvants to bupivacaine in TAP block in patients undergoing Cesarean Section and to evaluate postoperative analgesic requirements, side effects and level of patient satisfaction.

Timeline

Start
2023-12-20
Primary completion
2026-01-18
Completion
2026-01-18

Drugs

EvaluationDrugModalityDoseRoute
Comparator Magnesium Sulfate Other / unclassified 250 mg Other
Comparator Neostigmine Other / unclassified 500 ug Other

Indications

No indication recorded.